104 related articles for article (PubMed ID: 9659375)
1. In vivo manipulation of L1210 cell cycle phase distribution with alpha-difluoromethylornithine, 4-amidinoindan-1-one 2'-amidinohydrazone and N1-acetylspermine.
Dorhout B; Ferwerda H; Kingma AW; de Hoog E; Muskiet FA
Biochim Biophys Acta; 1998 Jun; 1381(1):89-94. PubMed ID: 9659375
[TBL] [Abstract][Full Text] [Related]
2. In vitro manipulation of L1210 cell cycle kinetics with 4-amidinoindan-1-one 2'-amidinohydrazone, alpha-difluoromethylornithine and N1-acetylspermine.
Dorhout B; Poortenga PJ; Kingma AW; de Hoog E; Muskiet FA
Biochim Biophys Acta; 1998 Jun; 1381(1):95-103. PubMed ID: 9659376
[TBL] [Abstract][Full Text] [Related]
3. In vivo effects of 4-amidinoindan-1-one 2'-amidinohydrazone (CGP 48664A) and alpha-difluoromethylornithine (DFMO) on L1210 growth, cell-cycle phase distribution and polyamine contents.
Dorhout B; te Velde RJ; Ferwerda H; Kingma AW; de Hoog E; Muskiet FA
Int J Cancer; 1995 Sep; 62(6):738-42. PubMed ID: 7558423
[TBL] [Abstract][Full Text] [Related]
4. In vivo growth inhibition of L1210 leukemia by 4-amidinoindan-1-one 2'-amidinohydrazone (CGP 48664A), a new inhibitor of S-adenosylmethionine decarboxylase.
Dorhout B; Te Velde RJ; Ferwerda H; Kingma AW; De Hoog E; Muskiet FA
Int J Cancer; 1995 Apr; 61(2):214-7. PubMed ID: 7705950
[TBL] [Abstract][Full Text] [Related]
5. 4-Amidinoindan-1-one 2'-amidinohydrazone (CGP 48664A) exerts in vitro growth inhibitory effects that are not only related to S-adenosylmethionine decarboxylase (SAMdc) inhibition.
Dorhout B; Odink MF; de Hoog E; Kingma AW; van der Veer E; Muskiet FA
Biochim Biophys Acta; 1997 Apr; 1335(1-2):144-52. PubMed ID: 9133651
[TBL] [Abstract][Full Text] [Related]
6. Stable intracellular acidification upon polyamine depletion induced by alpha-difluoromethylornithine or N1,N12-bis(ethyl)spermine in L1210 leukaemia cells.
Poulin R; Pegg AE
Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):749-56. PubMed ID: 8554515
[TBL] [Abstract][Full Text] [Related]
7. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
Regenass U; Mett H; Stanek J; Mueller M; Kramer D; Porter CW
Cancer Res; 1994 Jun; 54(12):3210-7. PubMed ID: 8205541
[TBL] [Abstract][Full Text] [Related]
8. Treatment of nude mice with 4-amidinoindan -1- one2 '- amidinohydrazone, a new S-adenosylmethionine decarboxylase inhibitor, delays growth and inhibits metastasis of human melanoma cells.
Gutman M; Beltran PJ; Fan D; Delworth MG; Singh RK; Wilson MR; Fidler IJ
Melanoma Res; 1995 Jun; 5(3):147-54. PubMed ID: 7640515
[TBL] [Abstract][Full Text] [Related]
9. Antileukemic effects of non-metabolizable derivatives of spermidine and spermine.
Ask A; Persson L; Seiler N; Heby O
Cancer Lett; 1993 Apr; 69(1):33-8. PubMed ID: 8481891
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy involving alpha-difluoromethylornithine and 1-beta-D-arabinofuranosylcytosine in murine L1210 leukemia.
Prakash NJ; Sunkara PS
Cancer Res; 1983 Jul; 43(7):3192-6. PubMed ID: 6406054
[TBL] [Abstract][Full Text] [Related]
11. Comparison and characterization of growth inhibition in L1210 cells by alpha-difluoromethylornithine, an inhibitor of ornithine decarboxylase, and N1,N8-bis(ethyl)spermidine, an apparent regulator of the enzyme.
Porter CW; Ganis B; Vinson T; Marton LJ; Kramer DL; Bergeron RJ
Cancer Res; 1986 Dec; 46(12 Pt 1):6279-85. PubMed ID: 3096560
[TBL] [Abstract][Full Text] [Related]
12. Major increases in spermidine/spermine-N1-acetyltransferase activity by spermine analogues and their relationship to polyamine depletion and growth inhibition in L1210 cells.
Libby PR; Henderson M; Bergeron RJ; Porter CW
Cancer Res; 1989 Nov; 49(22):6226-31. PubMed ID: 2804970
[TBL] [Abstract][Full Text] [Related]
13. CGP 48664, a potent and specific S-adenosylmethionine decarboxylase inhibitor: effects on regulation and stability of the enzyme.
Svensson F; Mett H; Persson L
Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):297-302. PubMed ID: 9078276
[TBL] [Abstract][Full Text] [Related]
14. Increased survival of L1210 leukemic mice by prevention of the utilization of extracellular polyamines. Studies using a polyamine-uptake mutant, antibiotics and a polyamine-deficient diet.
Ask A; Persson L; Heby O
Cancer Lett; 1992 Sep; 66(1):29-34. PubMed ID: 1451093
[TBL] [Abstract][Full Text] [Related]
15. Cellular pharmacology of N1- and N8-aziridinyl analogues of spermidine.
Yuan ZM; Egorin MJ; Rosen DM; Simon MA; Callery PS
Cancer Res; 1994 Feb; 54(3):742-8. PubMed ID: 8306336
[TBL] [Abstract][Full Text] [Related]
16. Effect of pretreatment with alpha-difluoromethylornithine on the selectivity of methylglyoxal bis(guanylhydrazone) for tumor tissue in L1210 leukemic mice.
Kramer DL; Paul B; Porter CW
Cancer Res; 1985 Jun; 45(6):2512-5. PubMed ID: 3921245
[TBL] [Abstract][Full Text] [Related]
17. Treatment with alpha-difluoromethylornithine plus a spermidine analog leads to spermine depletion and growth inhibition in cultured L1210 leukemia cells.
Casero RA; Bergeron RJ; Porter CW
J Cell Physiol; 1984 Dec; 121(3):476-82. PubMed ID: 6438117
[TBL] [Abstract][Full Text] [Related]
18. Comparative antitumor properties in rodents of irreversible inhibitors of L-ornithine decarboxylase, used as such or as prodrugs.
Claverie N; Mamont PS
Cancer Res; 1989 Aug; 49(16):4466-71. PubMed ID: 2501026
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of 1,3-bis(2-chloroethyl)-1-nitrosourea-induced cytotoxicity and DNA damage by alpha-difluoromethylornithine in L1210 leukemia cells.
Cavanaugh PF; Pavelic ZP; Porter CW
Cancer Res; 1984 Sep; 44(9):3856-61. PubMed ID: 6430555
[TBL] [Abstract][Full Text] [Related]
20. Biological properties of N4- and N1,N8-spermidine derivatives in cultured L1210 leukemia cells.
Porter CW; Cavanaugh PF; Stolowich N; Ganis B; Kelly E; Bergeron RJ
Cancer Res; 1985 May; 45(5):2050-7. PubMed ID: 3921235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
